DOCTEUR ELSA GENDEBIEN
ActiveSummary
DOCTEUR ELSA GENDEBIEN has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €84k and a net result of €12k. Equity is growing by ~31.4% per year across the filed fiscal years. Its solvency ranks better than 90% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2025
91
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability71▼-29
Solvency100=
Growth52=
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity ample (current ratio 17.67 against 8.87 in 2024; short-term debt: 5.7% and cash: 79.4% of total assets), and 5.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
94.3%
Return on assets
13.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
8 d early
2024
16 d early
2023
22 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€84k▲ 16.6%
2024 · €72k
2023: €39k
2024: €72k
2023 → 2025
Total assets
€89k▲ 9.7%
2024 · €81k
2023: €58k
2024: €81k
2023 → 2025
Net result
€12k▼ 64.1%
2024 · €33k
2023: €36k
2024: €33k
2023 → 2025
Working capital
€84k▲ 16.6%
2024 · €72k
2023: €39k
2024: €72k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€39k-€72k▲ 86.0%€84k▲ 16.6%
Operating result€48k-€45k▼ 5.6%€19k▼ 59.0%
Net result€36k-€33k▼ 8.1%€12k▼ 64.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 59% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €89k
Equity
€84k ▲ 16.6%
Debt
€5k ▼ 44.9%
Debt's share of the balance-sheet total falls from 11.3% to 5.7%. Equity is higher and debt is lower.
Key figures and ratios
Current ratio
17.67▲
2024 · 8.87
Debt to equity
0.06▼
2024 · 0.13
ROE
14.2%▼
2024 · 46.2%
ROA
13.4%▼
2024 · 41.0%
Debt ≤ 1 year
€5k▼
2024 · €9k
Income taxes
€4k▼
2024 · €9k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 29 lines
Balance sheet
Code20242025
Assets
Total assets20/58€81k€89k▲
Current assets29/58€81k€89k▲
Amounts receivable within one year40/41€2k€7k▲
Other amounts receivable41€2k€7k▲
Cash at bank and in hand54/58€60k€71k▲
Deferred charges and accrued income490/1€20k€11k▼
Equity and liabilities
Total equity and liabilities10/49€81k€89k▲
Equity10/15€72k€84k▲
Contributions10/11€3k€3k=
Profit (loss) carried forward14€70k€82k▲
Amounts payable17/49€9k€5k▼
Amounts payable within one year42/48€9k€5k▼
Taxes, remuneration and social security45€6k€5k▼
Taxes450/3€4k€2k▼
Remuneration and social security454/9€3k€3k▲
Other amounts payable47/48€3k€554▼
Income statement
Code20242025
Other operating charges640/8€220€840▲
Gross operating margin9900€45k€19k▼
Operating profit (loss)9901€45k€19k▼
Financial income75/76B-€132
Recurring financial income75-€132
Financial charges65/66B€3k€3k▼
Recurring financial charges65€3k€3k▼
Profit (loss) for the period before taxes9903€42k€16k▼
Income taxes67/77€9k€4k▼
Profit (loss) for the period9904€33k€12k▼
Profit (loss) for the period to be appropriated9905€33k€12k▼
Appropriation of the result
Profit (loss) to be appropriated9906€70k€82k▲
Profit (loss) brought forward from the previous period14P€36k€70k▲
The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €12k ▼64.1%
Net result drops to €12k, the lowest in the series.
15-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity triplescurrent ratio 8.87
Current ratio from 3.06 to 8.87; short-term debt falls from €19k to €9k.
09-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Liège · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Edouard-Wacken 134000 LiègeGround area
186 m²
Building footprint
58 m²
Volume, LiDAR
893 m³
Parcel 62805D0429/00K005, Wallonia · tallest building 17.7 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Rue Edouard-Wacken 13, 4000 Liège
since 20222.339.616.046
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62805D0429/00K005 | Wallonia | 186 m² | 1 · 58 m² | 17.7 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CD Médecine
BE 1000.132.455
Lessines · Eq €84,243
Dr Gabriel-M.P.E.M.P.
BE 0879.650.537
Braine-le-Château · Eq €84,207
Dr Van Osta David
BE 0795.395.743
Etterbeek · Eq €84,193
Van den Hooff-Verheyen
BE 0805.984.084
Ranst · Eq €84,158
DR PITON ALISON
BE 0673.840.291
Nivelles · Eq €84,348
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,143 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded06-12-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.